Equity Incentive Plans (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Stock Option Activity |
The following table summarizes stock option activity during the six months ended June 30, 2026: | | | | | | | | | | | | | | | | | | | | | | | | | Shares Subject to Options Outstanding | | Weighted- Average | | | | Shares | | Weighted- Average Exercise Price | | Remaining Contractual Life (Years) | | Aggregate Intrinsic Value | | | | | | | | (in thousands) | | Outstanding as of December 31, 2025 | 47,436,953 | | | $ | 1.74 | | | 7.4 | | $ | 84,257 | | | Options granted | 63,000,828 | | | $ | 0.91 | | | | | | | Options exercised | (211,460) | | | $ | 1.04 | | | | | | | Options forfeited/cancelled | (55,541,870) | | | $ | 1.74 | | | | | | | Outstanding as of June 30, 2026 | 54,684,451 | | | $ | 0.79 | | | 6.1 | | $ | — | | | Options vested and expected to vest as of June 30, 2026 | 54,684,451 | | | $ | 0.79 | | | 6.1 | | $ | — | | | Options exercisable as of June 30, 2026 | 27,944,056 | | | $ | 1.06 | | | 5.0 | | $ | — | |
|
| Schedule of Restricted Stock Activity |
The summary of the Company’s restricted stock grants activity during the six months ended June 30, 2026 is as follows: | | | | | | | | | | | | | Number of Restricted Stock Grants Outstanding | | Weighted- Average Grant Date Fair Value | | Nonvested at December 31, 2025 | 4,126,962 | | | $ | 1.71 | | | Granted | 4,039,821 | | | 2.88 | | | | | | | Forfeited | (1,608,868) | | | 2.17 | | | Nonvested at June 30, 2026 | 6,557,915 | | | $ | 2.31 | |
|
| Schedule of Stock-Based Compensation Expense Reported in Condensed Consolidated Statements of Operations |
Stock-based compensation expense has been reported in the Company’s condensed consolidated statements of operations and comprehensive loss as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended June 30, | | Six months ended June 30, | | | | 2026 | | 2025 | | 2026 | | 2025 | | | | | | Research and development | $ | 653 | | | $ | 1,328 | | | $ | 3,424 | | | $ | 2,466 | | | | | | | General and administrative | 1,810 | | | 1,258 | | | 5,343 | | | 2,525 | | | | | | | Total stock-based compensation expense | $ | 2,463 | | | $ | 2,586 | | | $ | 8,767 | | | $ | 4,991 | | | | | |
|
| Schedule of Fair Value of the Derivative Liability |
A summary of the changes in the fair value of the derivative liabilities Level 3 rollforward is as follows (in thousands): | | | | | | | Three Months Ended June 30, 2026 | | Beginning balance at June 4, 2026 | $ | 47,051 | | | Change in fair value in net gain | (4,113) | | | Ending balance at June 30, 2026 | $ | 42,938 | |
The summary of the changes in the fair value of the warrant liabilities Level 3 rollforward is as follows (in thousands): | | | | | | | Three Months Ended June 30, 2026 | | Beginning balance at June 4, 2026 | $ | 19,893 | | | Change in fair value in net gain | (1,602) | | | Ending balance at June 30, 2026 | $ | 18,291 | |
|